Kandhasamy Sreemanjari, Baggio Stéphanie, Mathis Jérôme, Mattmann Yolanda, Maisonneuve Emeline, Auer Reto, Panchaud Alice, Jenkinson Stephen P, Schoeni Anna
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Graduate School of Health Sciences, University of Bern, Bern, Switzerland.
PLoS One. 2025 Sep 25;20(9):e0332961. doi: 10.1371/journal.pone.0332961. eCollection 2025.
Tobacco smoking is associated with adverse health outcomes for both pregnant women and their offspring. Smoking cessation counseling is an effective method to help women quit smoking. Developing a targeted smoking cessation intervention could benefit those who struggle to quit tobacco and potentially reduce the harm due to any co-occurring tobacco use. Assessing the prevalence of tobacco, electronic nicotine delivery systems (ENDS), nicotine replacement therapy (NRT), and cannabinoid use in pregnancy is key to developing such interventions. Thus, we aimed to assess the prevalence and patterns of tobacco, ENDS, NRT, and cannabinoid use in pregnancy. We further aimed to assess the prevalence of smoking cessation counseling intervention.
We conducted a cross-sectional survey among pregnant women attending regular clinical visits at Spitalzentrum Biel between February and May 2023 (n = 262). Frequency and proportion along with 95% confidence intervals (CI) were reported for tobacco, ENDS, NRT, and cannabinoid use in pregnancy.
Tobacco use was reported among 7.6% (20/262, 95% CI: 4.2%-11.1%) of the included pregnant women. Tobacco cigarettes (conventional or roll-on) were used by 7.3% (19/262, 95% CI: 3.8%-10.7%) of the surveyed pregnant women, with 0.8% (2/262, 95% CI: 0.0%-3.4%) of them reporting use of cigarettes along with ENDS and 0.4% (1/262, 95% CI: 0.0%-3.8%) reporting use of the cigarettes with NRT. Cannabinoid use was reported by 3.8% (10/262, 95% CI: 1.1%-7.0%) of pregnant women and all of them used products with Cannabidiol (CBD) only. Additionally, only 25% (5/20, 95% CI: 10.0%-48.3%) of tobacco users had received smoking cessation counseling intervention.
The estimated prevalence of tobacco, ENDS, NRT, and cannabinoid use among the pregnant women in this survey was 7.6%, 0.8%, 0.4%, and 3.8% respectively. However, among tobacco users, only one-fourth received smoking cessation counseling intervention.
吸烟对孕妇及其后代的健康都有不良影响。戒烟咨询是帮助女性戒烟的有效方法。制定有针对性的戒烟干预措施可能会使那些难以戒烟的人受益，并有可能减少因同时使用烟草而造成的危害。评估孕期烟草、电子尼古丁传送系统（ENDS）、尼古丁替代疗法（NRT）和大麻素的使用情况，是制定此类干预措施的关键。因此，我们旨在评估孕期烟草、ENDS、NRT和大麻素的使用情况及模式。我们还旨在评估戒烟咨询干预措施的实施情况。
我们于2023年2月至5月期间，对在比尔斯中心医院进行定期产检的孕妇开展了一项横断面调查（n = 262）。报告了孕期烟草、ENDS、NRT和大麻素使用情况的频率、比例以及95%置信区间（CI）。
在所纳入的孕妇中，7.6%（20/262，95% CI：4.2% - 11.1%）报告有烟草使用情况。7.3%（19/262，95% CI：3.8% - 10.7%）的受调查孕妇使用香烟（传统香烟或卷制香烟），其中0.8%（2/262，95% CI：0.0% - 3.4%）报告同时使用香烟和ENDS，0.4%（1/262，95% CI：0.0% - 3.8%）报告同时使用香烟和NRT。3.8%（10/262，95% CI：1.1% - 7.0%）的孕妇报告使用过大麻素，且她们都仅使用含大麻二酚（CBD）的产品。此外，在吸烟的孕妇中，只有25%（5/20，95% CI：10.0% - 48.3%）接受过戒烟咨询干预。
本次调查中，孕妇烟草、ENDS、NRT和大麻素的估计使用率分别为7.6%、0.8%、0.4%和3.8%。然而，在吸烟的孕妇中，只有四分之一接受过戒烟咨询干预。
